These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27412291)

  • 21. Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice.
    Gao WR; Hu XH; Yu KY; Cai HY; Wang ZJ; Wang L; Wu MN
    Behav Brain Res; 2023 Feb; 438():114171. PubMed ID: 36280008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
    Biyong EF; Tremblay C; Leclerc M; Caron V; Alfos S; Helbling JC; Rodriguez L; Pernet V; Bennett DA; Pallet V; Calon F
    Neurobiol Dis; 2021 Dec; 161():105542. PubMed ID: 34737043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
    Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
    Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
    Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
    Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
    Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
    Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
    Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
    J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
    Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E; Wong AA; Vienneau NA; Brown RE
    Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.